Heritage Distilling Prices IPO-February 2024-www.financetom.com

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Heritage Distilling Prices IPO

Nov 22, 2024 6:58 AM

09:44 AM EST, 11/22/2024 (MT Newswires) -- Heritage Distilling (CASK) said Friday it priced its initial public offering of nearly 1.7 million shares at an initial public offering price of $4 per share, for gross proceeds of about $6.75 million.

Underwriters were given a 30-day over-allotment option to buy up to an additional 253,125 shares at the IPO price, less underwriting discounts and commissions, the company said.

Heritage said that all shares are being offered by the company.

The shares were slated to start trading Friday under the symbol 'CASK.'

The offering is expected to close Nov. 25.

Previous page： Pfizer Q3 Adjusted Earnings, Revenue Fall; Annual Adjusted EPS Outlook Upgraded Next page： Propanc Biopharma, Inc. Pursues Strategic Acquisition Plan Targeting Digital Asset Treasury (DAT) Companies Trading Below Market Cap to Net Asset Value (MNAV)

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Pfizer Q3 Adjusted Earnings, Revenue Fall; Annual Adjusted EPS Outlook Upgraded

Nov 4, 2025

06:58 AM EST, 11/04/2025 (MT Newswires) -- Pfizer ( PFE ) reported Q3 adjusted earnings Tuesday of $0.87 per diluted share, down from $1.06 a year earlier. Analysts polled by FactSet expected $0.63. Revenue for the quarter was $16.65 billion, compared with $17.70 billion a year earlier. Analysts surveyed by FactSet expected $16.5 billion. The company said it now expects...

Propanc Biopharma, Inc. Pursues Strategic Acquisition Plan Targeting Digital Asset Treasury (DAT) Companies Trading Below Market Cap to Net Asset Value (MNAV)

Nov 4, 2025

MELBOURNE, Australia, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. ( PPCB ) (“Propanc” or the “Company”), a biopharmaceutical company developing new treatments for patients suffering from recurrent and metastatic cancer, today announced a strategic initiative to pursue the acquisition of Digital Asset Treasury (DAT) companies that are currently trading below their Market Cap to Net Asset Value (MNAV)....

PJT Partners Q3 revenue up 37%, beats estimates

Nov 4, 2025

Overview * PJT Partners ( PJT ) Q3 revenue grows 37% yr/yr, beating analyst expectations * Adjusted EPS for Q3 beats consensus, reflecting strong financial performance * Company repurchased 2.3 mln shares, indicating confidence in future growth Result Drivers * STRATEGIC ADVISORY - Increase in strategic advisory revenues drove higher Q3 revenue * FUND PLACEMENT - Increase in fund placement...

Molson Coors Beverage Q3 Non-GAAP Earnings, Net Sales Decline

Nov 4, 2025

06:58 AM EST, 11/04/2025 (MT Newswires) -- Molson Coors Beverage ( TAP/A ) reported Q3 non-GAAP earnings Tuesday of $1.67 per diluted share, up/down from $1.80 a year earlier. Analysts polled by FactSet expected $1.69. Net sales for the quarter ended Sept. 30 were $2.97 billion, down from $3.04 billion a year earlier. Analysts surveyed by FactSet expected $3.01 billion....